Medical/Pharmaceuticals
More Ingredients, Better Supplements? Totaria Shares What Midlife Women Should Look For
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- As World Menopause Day
2026-10-15 23:12
1399
Lunit SCOPE Reveals HER2 Expression Differences Linked to Treatment Response Beyond Conventional Testing in Nature Medicine Study
AI-powered whole-slide analysis provides insights into treatment response beyond conventional HER2 classification SEOUL, South Korea, Oct. 14, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced findings from a study p...
2026-10-14 21:00
1568
Neurophet Honored with Two Awards at the BioSpectrum Asia Excellence Awards 2026
* Receives Awards for MedTech Innovation and AI-Driven Clinical Development; Only Korean Company Recognized in Two Categories * Recognized for its capabilities in AI-driven clinical support and ICL services, with plans to expand partnerships with global CROs SEOUL, South Korea, Oct. 14, 2026 /...
2026-10-14 21:00
1332
MIRACELL to Host Stem Cell Science Day 2026 in Los Angeles, Featuring International Clinical Insights in Regenerative Medicine
- Leading South Korean and U.S. medical experts to share clinical insights into regenerative medicine - Austrian clinical study on 47 ACL rupture patients treated with SMART M-CELL published in peer-reviewed journal LOS ANGELES, Oct. 14, 2026 /PRNewswire/ -- Miracell U.S. Inc., the U.S. subsidi...
2026-10-14 19:00
1339
Prof. Gang Shen Named Among World's Top 2% Scientists for Fourth Consecutive Year
SHANGHAI, Oct. 14, 2026 /PRNewswire/ -- Prof. Gang Shen of Taikang ByBo Dental has been named among theWorld's Top 2% Scientists for the fourth consecutive year, according to the ninth edition of the database jointly released by Stanford University and Elsevier. Prof. Shen has been recognised on...
2026-10-14 18:18
1045
Datasea's Five AI Agent Customer Arrangements Reach Approximately US$4.0 Million in Aggregate Service Value
Aggregate service value increased approximately 264% from the approximately US$1.10 million disclosed in mid-September; continued execution advances AI agent commercialization under arrangements previously disclosed with potential annualized service volume of up to approximately US$89.4 million ...
2026-10-13 21:30
5178
AI-driven Molecular Glue Innovation: Insilico Nominates ISM9546, an Oral, Peripheral-Restricted VAV1 Degrader as PCC for Autoimmune Diseases
* Sustained Boost in AI-Driven R&D Productivity: ISM9546 marks Insilico Medicine's 35th preclinical candidate (PCC) nominated since 2021 and its 11th PCC within the first 10 months of 2026 alone, setting a new record for the company's annual pipeline output efficiency. * AI-Enabled Molecular ...
2026-10-13 21:00
3346
Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China
Hiteck grants Visara, a majority-owned ophthalmology subsidiary of NovaBridge Biosciences (NASDAQ: NBP), exclusive worldwide rights, excluding Greater China, to develop and commercialize HT006.2.2 Hiteck retains all rights in Greater China, where a Phase 1b study in severe neurotrophic keratitis...
2026-10-13 19:00
2044
ELEHEAR Earns Two 2026 Hearing Technology Innovator Awards™ from Hearing Health & Technology Matters
Beyond 2 Pro and ElePro® Plus awarded industry recognition as ELEHEAR continues
its mission to make personalized hearing care more accessible
CHICAGO, Oct. 13, 2026 /PRNewswire/ -- ELEHEAR
2026-10-13 19:00
1651
Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research
Collaboration expands access to Lunit's AI-powered pathology platform by combining it with Discovery Life Sciences' global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development. SEOUL, South Korea, Oct. 12, 2026 /PRNe...
2026-10-12 21:00
1893
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
GUANGZHOU, China, Oct. 12, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today highlighted its strategy to participate in the ongoing transformatio...
2026-10-12 20:00
1194
CLASSYS Appoints Former Bain & Company Partner Jung-hee Bae as Chief Commercial Officer to Accelerate Global Expansion and Growth
- Appoints Vice President Jung-hee Bae to lead the newly established Go-to-Market (GTM) Center, overseeing domestic and international sales and marketing - AI and data-driven marketing and operations expert to spearhead expansion across the Americas, China and Europe while reinforcing the company...
2026-10-12 14:49
3336
Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
* New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely active Crohn's disease and ulcerative colitis * Late-breaking analysis shows significantly higher rat...
2026-10-12 01:00
3838
First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer
HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as monotherapy in the neoa...
2026-10-10 12:41
3054
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
GUANGZHOU, China, Oct. 9, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that it received a staff determination letter (...
2026-10-10 04:05
3453
Dr. Vein, a Specialist Varicose Vein Clinic in Ho Chi Minh City, Sets Out Its Treatment Pathway for Patients Travelling from the United States
HO CHI MINH CITY, Vietnam, Oct. 9, 2026 /PRNewswire/ -- Dr. Vein Clinic, a medical facility in central Ho Chi Minh City specializing in the examination and treatment of varicose veins, has set out the treatment pathway it uses for patients who travel to Vietnam for care. The clinic treats lower l...
2026-10-09 16:43
4992
India Mental Health Alliance (IMHA) champions lived experience as central to shaping mental healthcare practice, service design and policy
NEW DELHI, Oct. 9, 2026 /PRNewswire/ -- On the occasion of World Mental Health Day (10th October), the India Mental Health Alliance (IMHA), a cross-sectoral network of 400 organisations from 30 Indian states, reaffirms its commitment to recognising lived experience as expertise, ensuring that the...
2026-10-09 16:00
4284
Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease
* SYCUME® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid Eye Disease(TED) SAN FRANCISCO and SUZHOU, China, Oct. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX...
2026-10-09 08:00
3638
Wellysis Secures FDA 510(k) Clearance for AI-Powered ECG Analysis Software, S-Patch CardioAI
* Adds FDA-cleared AI analysis to Wellysis' S-Patch ECG monitoring solution, expanding its capabilities beyond ECG acquisition * Enables FDA-cleared AI analysis of S-Patch ECG data to be integrated into third-party ECG platforms and existing clinical workflows * Designed to streamline ECG re...
2026-10-08 22:00
4263
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering
TAIZHOU, China, Oct. 8, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 8,000,000 Class A ordinary shares of the co...
2026-10-08 21:22
6722
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 281 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 279 media titles]
2026-10-15 12:59
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21Most Read
Amap and Sands China mark the delivery of the first Tutu robots, with expected indoor navigation and 3D resort previews
2026-10-10 16:43
15237
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
2026-10-13 10:00
12340
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
12237